198 related articles for article (PubMed ID: 16301583)
21. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
22. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
23. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of galectin-3 in canine mammary tumours.
Choi YK; Hong SH; Kim BH; Kim HC; Woo HJ; Kim DY
J Comp Pathol; 2004; 131(2-3):242-5. PubMed ID: 15276865
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
29. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
30. Expression of maspin in mammary gland tumors of the dog.
Espinosa de los Monteros A; Millán MY; Ramírez GA; Ordás J; Reymundo C; Martín de las Mulas J
Vet Pathol; 2005 May; 42(3):250-7. PubMed ID: 15872371
[TBL] [Abstract][Full Text] [Related]
31. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
[TBL] [Abstract][Full Text] [Related]
34. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
35. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
36. Haemoglobin in normal and neoplastic canine mammary glands.
Chang SC; Chen HF; Chou MH; Wang HC; Su HY; Wong ML
Vet Comp Oncol; 2010 Dec; 8(4):302-9. PubMed ID: 21062412
[TBL] [Abstract][Full Text] [Related]
37. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.
Klopfleisch R; Schütze M; Gruber AD
Vet J; 2010 Dec; 186(3):379-84. PubMed ID: 19836277
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
Klopfleisch R; Gruber AD
Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
[TBL] [Abstract][Full Text] [Related]
40. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
